Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,966.00p
   
  • Change Today:
    -7.00p
  • 52 Week High: 2,205.00
  • 52 Week Low: 1,722.00
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 54,897
  • Market Cap: £4,362.26m
  • RiskGrade: 125

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CEO: Riad Mishlawi
Executive Chairman: Said Darwazah
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Laura Balan Balan
Independent Non-Executive Director: Mary (Nina) Henderson
Independent Non-Executive Director: Victoria Hull
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: Deneen Vojta
Independent Non-Executive Director: Douglas Hurt
Independent Non-Executive Director: John J. Castellani
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:HIKL
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,966.00p
Change Today -7.00p
% Change -0.35 %
52 Week High 2,205.00
52 Week Low 1,722.00
Volume 54,897
Shares Issued 221.89m
Market Cap £4,362.26m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.58% below the market average48.58% below the market average48.58% below the market average48.58% below the market average48.58% below the market average
5.88% below the sector average5.88% below the sector average5.88% below the sector average5.88% below the sector average5.88% below the sector average
Price Trend
52.61% above the market average52.61% above the market average52.61% above the market average52.61% above the market average52.61% above the market average
69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average
Income
10.61% above the market average10.61% above the market average10.61% above the market average10.61% above the market average10.61% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
36.71% below the market average36.71% below the market average36.71% below the market average36.71% below the market average36.71% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 07-Jun-2024

Time Volume / Share Price
14:24 99 @ 1,967.00p
14:24 99 @ 1,967.00p
14:24 99 @ 1,967.00p
14:24 99 @ 1,967.00p
14:23 99 @ 1,967.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page